Dernières nouvelles pour Cushman & Wakefield (NYSE:CWK) Stock

Cushman & Wakefield

Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such valuation, project management, and facilities management.

Cushman & Wakefield PLC

Immutep Limited&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) on Thursday announced additional data from the investigator-initiated INSIGHT-003 trial evaluating a triple combination therapy in front-line <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">non-small cell lung cancer patients</a> consisting of efti administered in conjunction with Merck &amp; Co Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) Keytruda (pembrolizumab) and chemotherapy (carboplatin and pemetrexed).
The company said it achieved a 60.8% response rate and 90.2% disease control rate as of the data cut-off <a href="https://www.benzinga.com/pressreleases/25/05/g45434128/immuteps-efti-with-keytruda-pembrolizumab-chemotherapy-achieves-high-response-rates-in-first-line-" target="_blank" rel="noreferrer noopener">date of May 6, 2025</a>.
Marc Voigt, CEO of Immutep, stated, &#8220;Our level of confidence in efti driving a new standard of care for patients with non-small cell lung cancer via our pivotal TACTI-004 trial continues to rise with the strength of the data from INSIGHT-003 and TACTI-002. Across two trials we have now efficacy data from 165 patients with 1L NSCLC who have been treated with efti and KEYTRUDA, either with or without chemotherapy. In multi-national settings, efti has generated consistent and remarkable improvements in response rates. In particular, the interim ORR data in patients with PD-L1 expression below 50% in the ongoing INSIGHT-003 trial, who represent over two-thirds of the 1L NSCLC patient population, is very encouraging.&#8221;
Data from all evaluable patients demonstrates significant improvement of Overall Response Rate (ORR) across all levels of PD-L1 expression compared to historical control from a registrational trial of anti-PD-1 and doublet chemotherapy in non-squamous 1L NSCLC1:
<ul class="wp-block-list">
<li>75.0% ORR versus 62.1% ORR in patients with high PD-L1 expression (TPS&nbsp;&gt;50%).</li>
<li>64.0% ORR versus 49.2% ORR in patients with low PD-L1 expression (TPS 1-49%).</li>
<li>54.5% ORR versus 32.3% ORR in patients with negative PD-L1 (TPS &lt;1%).</li>
</ul>
The 60.8% response rate, regardless of PD-L1 expression (TPS 0-100%), represents a substantial improvement compared to the historical control of 48.0%.
The relative outperformance is particularly strong given the registrational trial has four times as many patients with high PD-L1 expression (~32% of patients versus ~8% in INSIGHT-003), who have the highest response rates.
In patients with TPS &lt;50% (N=47), who have a high unmet need and represent over two-thirds of the 1L NSCLC patient population, the triple combination with efti achieved a 59.6% response rate compared to a historical control of 40.8%.
Safety continues to be favorable for the triple combination in 1L NSCLC with no new safety signals.
Additional data updates from this trial are expected to be presented at a medical conference in 2025 and beyond.
In May, Immutep announced that the median Overall Survival (OS) of 17.6 months had been achieved in Cohort B of the TACTI-003 <a href="https://www.benzinga.com/pressreleases/25/05/g45191374/immuteps-efti-in-combination-with-keytruda-pembrolizumab-drives-strong-overall-survival-in-head-an" target="_blank" rel="noreferrer noopener">(KEYNOTE-C34) Phase 2b trial</a>.
This part of the Phase 2 study evaluates eftilagimod alfa (efti) in combination with Keytruda as first-line therapy in recurrent/metastatic head and neck squamous cell carcinoma.
Immutep dosed the first patient in its pivotal TACTI-004 Phase 3 trial in March.
TACTI-004 will evaluate Immutep&#8217;s eftilagimod alfa in combination with Keytruda as first-line treatment for patients with advanced or metastatic <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44471381/first-patient-dosed-in-immuteps-tacti-004-phase-iii-trial-in-first-line-non-small-cell-lung-cancer" rel="noreferrer noopener">non-small cell lung cancer</a>.
Price Action: IMMP stock is up 9.2% at $2.00 at last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45443786/workhorse-stock-slides-after-q1-miss-plans-to-cut-workforce-to-curb-cash-burn" target="_blank" rel="noreferrer noopener">Workhorse Stock Slides After Q1 Miss, Plans To Cut Workforce To Curb Cash Burn</a></li>
</ul>
Photo: Shutterstock

Biotech

News

Health Care

Movers

Trading Ideas

General

IMMP

Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo

Five weeks ago, markets and businesses were bracing for the worst. Donald Trump's sweeping April 2 tariff announcement sparked panic across equities and credit markets, igniting fears of <a href="https://www.benzinga.com/topic/tariffs">a trade-driven recession. </a>
But fast forward to mid-May, and the last traces of that economic pessimism have been wiped out. From credit spreads to the traditional Wall Street&#8217;s stress indicator, the message is clear: Investors are no longer pricing in a U.S. recession.
<h3 class="wp-block-heading">Tariff-Driven Credit Risk? Gone</h3>
High-yield bond spreads — one of the market&#8217;s most reliable gauges of economic stress — have returned to pre-tariffs levels.
The spread between U.S. high yield corporate bonds and Treasurys has dropped from 4.7 percentage points in early April to just 3.1 percentage points, now below the three-year average of 3.86. This signals investor confidence in even the riskiest borrowers' ability to meet debt obligations.
&#8220;During a huge risk-on advance, US High yield spreads have tightened 152 bps since April 7. With spreads now at 309 bps above Treasuries, credit market investors are back to pricing in a very optimistic outlook with no recession and few defaults,&#8221; Charlie Bilello, chief market strategist at Creative Planning, wrote in a <a href="https://x.com/charliebilello/status/1922746726307311890">post on X.com</a>.
Even in the riskiest corners of the market, sentiment has flipped. 
CCC-rated bonds, which sit just above default status, now trade at an 8.74-point spread, down from an April 7 peak of 11.4, and well below their 3-year average of 9.66.
The BondBloxx CCC-rated USD High Yield Corporate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XCCC#NYSE">XCCC</a>) has rallied 13% since April 7, marking the best 26-day rise since the fund&#8217;s inception in 2022. 
This reset in credit risk pricing reflects not only a shift in sentiment but also the market's perception that tariff-induced recession risks have been neutralized. 
<h3 class="wp-block-heading">Chart: Junk Bonds Are Breathing Easy Again After Tariff Shock</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="529" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15121610/image-185-1024x529.png" alt="" class="wp-image-916861" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15121610/image-185-1024x529.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15121610/image-185-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15121610/image-185-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15121610/image-185-1536x793.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15121610/image-185-2048x1058.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">Volatility Vanishes As Wall Street Gets Its Calm Back</h3>
The CBOE Volatility Index (VIX) — Wall Street's fear gauge — had spiked to 60 on April 7, a level not seen since the pandemic crash. 
But with the White House&#8217;s 90-day pause on tariffs and tangible diplomatic progress — including a May 12 U.S.-China trade truce and a May 7 U.S.-UK trade agreement — clarity returned, and with it, calm.
On May 15, the VIX hovered around 18 levels, marking a 70% drop from last month&#8217;s peak. 
&#8220;Clarity often breeds comfort, and the removal of worst-case trade war scenarios meant the market could move on from peak fear,&#8221; said in an email Adam Turnquist, chief technical strategist for LPL Financial.
Dominic Wilson, analyst at Goldman Sachs, said the reduction in China-U.S. tariffs has led the bank to raise its U.S. growth forecast and lower recession odds. 
"We see some scope for near-term relief to continue," Wilson said, although he warned about renewed pressure on long-term interest rates and called for downside protection ahead of labor data.
CFTC-regulated betting platform Kalshi now assigns a 40% probability of a U.S. recession this year, down from 70% a month ago — suggesting it's now more likely the economy avoids a downturn.
<iframe loading="lazy" src="https://kalshi.com/external-widgets/events/RECSSNBER-25/markets/RECSSNBER-25?color_scheme=dark&#038;widget_size=medium&#038;variant=a&#038;utm_campaign=benzinga_widget" width="488px" height="242px" style="border:0"></iframe>
<h3 class="wp-block-heading">Markets Enter Phase 2: Communication Services, Tech Lead</h3>
Markets are now transitioning into what Jeff Buchbinder, LPL Financial's chief equity strategist, calls "phase two" — a low-tariff, trade-clarity regime. 
During this period, sectors exposed to global supply chains and discretionary spending are expected to outperform, according to the expert.
Buchbinder said communication services, consumer discretionary, industrials, and technology top his list, with the former seen as the standout.
The communication services sector has the highest percentage of cost of goods sold sourced outside the U.S. among S&amp;P 500 sectors, as LPL noted citing Bloomberg data, making it a prime beneficiary of easing trade tensions. 
The sector also boasts the lowest price-to-earnings ratio, biggest first-quarter earnings upside surprise, and second-best earnings growth among all 11 S&amp;P sectors.
From collapsing volatility to tightening credit spreads and a bullish sector rotation, markets are sending a clear signal: recession fears are in the rearview mirror, at least for now.
Read now: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45420871/gold-miners-slammed-by-us-china-trade-truce-is-it-time-to-take-profit">Gold Miners Slammed By US-China Trade Truce: Is It Time To Take Profit? </a></li>
</ul>
Photo: Shutterstock

Analyst Color

Equities

Government

Large Cap

Macro Economic Events

Bonds

Specialty ETFs

Economics

Markets

Analyst Ratings

ETFs

BondBloxx ETF Trust BondBloxx CCC-Rated USD High Yield Corporate Bond ETF

XCCC

What Recession? Markets Have Erased Every Last Bit Of Economic Pessimism

Nkarta Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTX#NASDAQ">NKTX</a>) on Wednesday reported a first-quarter loss of 43 cents per share, beating the consensus loss of 44 cents.
As of March 31, 2025, Nkarta had $351.9 million in cash, cash equivalents, restricted cash, and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45419324/nkarta-reports-first-quarter-2025-financial-results-and-corporate-highlights" rel="noreferrer noopener">investments in marketable securities</a>.
The company expects its current cash and cash equivalents to be sufficient to fund its current operating plan into 2029.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44519736/why-is-autoimmune-disease-focused-nkarta-stock-trading-higher-on-thursday" rel="noreferrer noopener">Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday</a>?
In the clinical development of NKX019 for autoimmune diseases, the Ntrust-1 trial of NKX019 for lupus nephritis (LN) expanded to include patients with primary membranous nephropathy (pMN). Ntrust-1 is currently open to enrolling patients with pMN and remains open to enrolling patients with LN.
The Ntrust-2 trial of NKX019 for systemic sclerosis, idiopathic inflammatory myopathy, and anti-neutrophil cytoplasmic antibody-associated vasculitis continues to enroll patients.
Ntrust-1 and Ntrust-2 protocols were amended to modify lymphodepletion before administration of NKX019 to use a combination of fludarabine and cyclophosphamide, with the option for eligible patients to continue to receive cyclophosphamide alone as modified lymphodepletion.
The investigator-sponsored trial (IST) of NKX019 for myasthenia gravis, led by researchers at the University of California, Irvine, has <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42334378/nkarta-announces-ind-clearance-of-investigator-sponsored-trial-in-myasthenia-gravis-and-opening-of" rel="noreferrer noopener">opened for enrollment</a>. The IST of NKX019 for systemic lupus erythematosus, led by researchers at Columbia University Irving Medical Center, remains open for enrollment. Preliminary clinical data from the Ntrust-1 and Ntrust-2 clinical trials are planned for the second half of 2025.
Analyst at William Blair said, &#8220;We view the expansion into pMN positively as it is the first cell therapy trial targeting pMN, to our knowledge, suggesting there will be minimal competition for patient enrollment compared to other indications like lupus nephritis.&#8221;
Analyst Sami Corwin is concerned about the changes to the protocol that added Flu to the preconditioning treatment. It&#8217;s unclear whether this decision was partly based on early trial data. &#8220;Without using a reduced lymphodepletion regimen, it&#8217;s becoming harder to see how NKX019 stands out from other CD19 allogeneic cell therapies in the crowded autoimmune disease market,&#8221; adds Corwin.
&#8220;In addition, while we look forward to the initial clinical data from the Ntrust-1 and Ntrust-2 trials in the second half of 2025, it is unclear if enough data will be shared for the data to be meaningful catalysts, and we think investors will have to wait until 2026 to get a more robust dataset,&#8221; the analyst says.
William Blair has downgraded Nkarta from <a target="_blank" href="https://www.benzinga.com/quote/NKTX/analyst-ratings" rel="noreferrer noopener">Outperform to Market Perform</a> and writes that the allogeneic approach is favorable for autoimmune disease. However, it is unclear how differentiated the CAR-NK approach is compared to other allogeneic CAR therapies in the space. The analyst has increased the full-year 2025 net loss estimate to $144.7 million, or $1.95 per share.
William Blair acknowledges the potential of Nkarta&#8217;s pMN expansion but has become more cautious due to concerns about the modified lymphodepletion protocol and the resulting uncertainty about NKX019&#8217;s differentiation in a competitive autoimmune market. They believe the current valuation reflects the risks and development stage.
Price Action: NKTX stock is trading lower by 8.02% to $1.72 at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45443025/birkenstock-ceo-is-confident-tariffs-is-not-a-disadvantage-for-the-brand" target="_blank" rel="noreferrer noopener">Birkenstock CEO Is Confident Tariffs Is Not A Disadvantage For The Brand</a></li>
</ul>
Image via Shutterstock

Downgrades

NKTX

Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space

WIIM

RCKT

Rocket Pharmaceuticals shares are trading higher after the company presented preliminary data from its  Phase 1 trial of RP-A601.

<a href="https://www.bloomberg.com/news/articles/2025-05-15/coinbase-says-bribed-workers-leaked-data-to-hacker-seeking-20-million-in-ransom" title="https://www.bloomberg.com/news/articles/2025-05-15/coinbase-says-bribed-workers-leaked-data-to-hacker-seeking-20-million-in-ransom">https://www.bloomberg.com/news/articles/2025-05-15/coinbase-says-bribed-workers-leaked-data-to-hacker-seeking-20-million-in-ransom</a>

COIN

Reported Earlier: 'Coinbase Hackers Had Access To Customer Data Since January' - Bloomberg News

<a href="http://www.msn.com/en-us/money/news/what-s-going-on-with-rivian-rivn-stock/ar-BB1q1OUt?ocid=finance-verthp-feeds&amp;apiversion=v2&amp;noservercache=1&amp;domshim=1&amp;renderwebcomponents=1&amp;wcseo=1&amp;batchservertelemetry=1&amp;noservertelemetry=1"></a><a href="http://www.msn.com/en-us/money/news/what-s-going-on-with-rivian-rivn-stock/ar-BB1q1OUt?ocid=finance-verthp-feeds&amp;apiversion=v2&amp;noservercache=1&amp;domshim=1&amp;renderwebcomponents=1&amp;wcseo=1&amp;batchservertelemetry=1&amp;noservertelemetry=1"></a>Rivian Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) shares are trading higher and trending Thursday. Here's what investors are watching with Rivian this week.
What To Know: The electric vehicle maker posted <a href="https://www.benzinga.com/news/earnings/25/05/45236756/rivian-q1-earnings-double-beat-record-gross-profit-delivery-estimates-lowered-on-tariff-concerns">better-than-expected</a> first-quarter results on May 6, reporting revenue of $1.24 billion (up 3% year-over-year) and a narrower-than-expected loss of 48 cents per share. Gross profit came in at $206 million—its second consecutive positive quarter—driven by improved cost efficiency and operational progress.
CEO RJ Scaringe emphasized Rivian&#8217;s <a href="https://www.benzinga.com/markets/equities/25/05/45243985/rivian-holds-firm-on-45k-r2-price-despite-tariff-pressures-ceo-rj-scaringe-says-its-important-for-us-as-ev-maker-tops-q1-estimates">ongoing development</a> of the R2 platform, with validation builds underway and its Illinois facility expansion on track. The R2, expected to launch in the first half of 2026, will enter the market at a starting price of $45,000, a level Rivian is maintaining despite rising tariffs. The company estimates per-unit tariff costs of around $2,000 in 2025.
Read Also: <a href="https://www.benzinga.com/news/25/05/45445582/plug-power-stock-hits-a-new-52-week-low-whats-going-on">Plug Power Stock Hits A New 52-Week Low: What&#8217;s Going On?</a>
Rivian also highlighted new milestones: a record 36,000 demo drives in the first-quarter, a fleet deal with HelloFresh and a $1 billion investment from Volkswagen set to close mid-2025. However, the company revised its 2025 delivery guidance downward to 40,000–46,000 vehicles, citing macroeconomic and trade uncertainties.
Adding some potential pressure this week, a new GOP-led House bill aims to <a href="https://www.benzinga.com/markets/equities/25/05/45366272/republicans-target-ev-perks-with-new-bill-ford-tesla-rivian-face-fallout-as-200-billion-in-battery-belt-investments-hang-in-balance">eliminate EV tax credits</a> and rescind billions in clean vehicle loan funding—including $6.57 billion allocated to Rivian.
Read Also: <a href="https://www.benzinga.com/news/25/05/45445161/nio-stock-is-sliding-thursday-whats-going-on">NIO Stock Is Sliding Thursday: What&#8217;s Going On?</a>
Price Action: Shares of Rivian have climbed 10% over the past week, trading at $15.22 Thursday afternoon.
<h2 class="wp-block-heading">How To Buy RIVN Stock</h2>
By now you're likely curious about how to participate in the market for Rivian Automotive &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, RIVN has a 52-week high of $18.86 and a 52-week low of $9.50.

RIVN

What's Going On With Rivian (RIVN) Stock?

<a href="https://bakkt.com/blog/bakkt-adds-seven-more-coins">https://bakkt.com/blog/bakkt-adds-seven-more-coins</a>
At Bakkt, we take pride in our position as a leader in cryptocurrency trading and infrastructure and&nbsp;a world-class partner in growth for our partners and customers. As we&nbsp;keep&nbsp;pace with the rapidly expanding ecosystem of tokens, we're thrilled to announce the launch of 7 new supported tokens on our trading platform. These newly approved assets bring Bakkt's current total supported assets to 39.
The following tokens are now available for trading in all U.S. states and jurisdictions where Bakkt operates:
<ul>
<li>APE - ERC20</li>
<li>COMP - ERC20</li>
<li>CRV - ERC20</li>
<li>FIL - Native</li>
<li>ICP - Native</li>
<li>POL - Native</li>
</ul>
The following tokens are now available for trading in all supported jurisdictions other than New York State:
<ul>
<li>GALA - ERC20</li>
</ul>

Bakkt Holdings, Inc. Class A Common Stock

BKKT

'Coin Listing: Bakkt Adds Seven More Coins to Platform' - Bakkt

Agape ATP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) reported quarterly losses of $(0.07) per share. This is a 61.11 percent increase over losses of $(0.18) per share from the same period last year. The company reported $289.04 thousand in sales this quarter. This is a 9.29 percent decrease over sales of $318.64 thousand the same period last year.

Earnings

ATPC

Agape ATP Q1 EPS $(0.07) Up From $(0.18) YoY, Sales $289.04K Down From $318.64K YoY

Costco Wholesale Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) shares are trending on Thursday with shares up more than 1.5%. Here&#8217;s a look at <a href="https://www.benzinga.com/news/earnings/25/05/45436534/walmart-doesnt-alter-annual-outlook-yet-ceo-says-all-tariffs-create-cost-pressures-but-china-has-biggest-impact">what&#8217;s going on</a>.
What To Know: Costco shares are moving higher Thursday, adding to gains of nearly 10% since the start of the year. The stock has almost recovered all of its losses since its last earning report in early March, which included a <a href="https://www.benzinga.com/news/earnings/25/03/44180426/costco-q2-earnings-revenue-beat-eps-miss-comps-up-6-8-driven-by-strength-in-the-us">shortfall on earnings</a>. Management also provided cautious commentary on the earnings call in anticipation of tariffs.
The stock appears to be getting a boost from Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) earnings on Thursday. Walmart shares initially traded higher on the report, and Costco shares followed. Walmart shares have since pulled back, but Costco shares are holding onto gains. 
On the conference call, Walmart executives noted that February was soft, but demand returned to normal in March and was stronger than expected in April. Walmart also reaffirmed its guidance for full-year 2025, which may be fueling some optimism for Costco&#8217;s upcoming report.
Costco is due to report fiscal third-quarter results in the coming weeks. The company is expected to report earnings of $4.24 per share and revenue of $63.21 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates. 
Costco said last week that net sales in April were up 7% on a year-over-year basis. Net sales since the start of the year were up 8.2%, the membership-based wholesale retailer said. 
JPMorgan reiterated an Overweight rating on Costco last week, highlighting <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45298451/jpmorgan-sees-more-upside-for-costco-as-us-sales-e-commerce-outperform">strong global momentum</a> and a rebound in big-ticket items, which account for about 20% of the retailer&#8217;s core sales.
It&#8217;s worth noting that Costco also showed up on Benzinga&#8217;s <a href="https://www.benzinga.com/trading-ideas/25/05/45335286/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-64">&#8220;Stock Whisper&#8221; index</a> last week, suggesting investors are optimistic about the stock with earnings on the horizon. 
Costco on Wednesday announced a multi-year partnership <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45414504/affirm-brings-buy-now-pay-later-to-costco-shoppers">with Affirm</a>, adding pay-over-time options for Costco.com in the U.S. Costco&#8217;s e-commerce sales climbed 12.6% year-over-year in April. 
COST Price Action: <a href="http://benzinga.com/quote/cost">Costco shares</a> were up 1.50% at $1,006.46 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45435725/tariffs-slow-retail-spending-as-producer-prices-post-sharpest-drop-since-2020">Tariffs Slow Retail Spending As Producer Prices Post Sharpest Drop Since 2020</a></li>
</ul>
Photo: teve Travelguide/Shutterstock.

Previews

COST

Costco Stock Is Trending Thursday: What's Going On?

A Reddit user recently shared a frustrating discovery in a <a href="https://www.reddit.com/r/mildlyinfuriating/comments/1kiuz4m/my_mom_says_we_dont_have_enough_money_but_i_catch/">post</a> titled, &#8220;My mom says we don't have enough money, but I catch her giving thousands of dollars monthly to a megachurch.&#8221;&nbsp;
The post included a screenshot of a recent $600 donation receipt to Bill Winston Ministries. It showed $300 for tithes, $100 for missions, and $30 for the &#8216;Airplane Fund.&#8217;
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
<h2 class="wp-block-heading">Financial Strain and Surprising Expenses</h2>
The post blew up with responses, with many calling out how <a href="https://www.benzinga.com/personal-finance/25/04/44587016/dave-ramsey-says-a-600k-salary-should-be-enough-so-why-is-this-couple-living-paycheck-to-paychec">wild some of the expenses</a> were. One user pointed out the irony of the airplane fund, saying, &#8220;Airplane Fund is literally paying for the owner&#8217;s private jet lol.&#8221; Another added, &#8220;And ‘tributes to BWM' is a typo: they meant BMW.&#8221;
Some jumped in to share their own stories about parents who put church donations ahead of basic needs. One wrote, &#8220;I grew up in one of these churches. My mom was tithing 20 percent during the ‘08 financial crisis. We were on a Spaghetti-O diet because of this sh&#8217;t. It's f&#x2A;&#x2A;ed because the deeper you go, the worse it gets.&#8221;
Others expressed frustration over the perceived <a href="https://www.benzinga.com/personal-finance/24/10/41659628/i-am-the-financial-power-of-attorney-but-they-dont-tell-me-anything-woman-seeks-suze-ormans-advi">financial exploitation</a>. One user said, &#8220;She&#8217;s correct. That&#8217;s why you don&#8217;t have enough money.&#8221;&nbsp;
Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a>
Others noted the emotional and psychological hold these churches can have. One person commented, &#8220;She is playing slots. They promise if she gives enough that God will also make her wealthy beyond her dreams.&#8221; Another added, &#8220;Slots have better odds. Lotto has even better odds.&#8221;
The post also sparked a debate about the morals of prosperity gospel teachings, which often promise financial blessings in exchange for donations. One user summed it up by saying, &#8220;Prosperity gospel is poison.&#8221;
Some even shared advice for the original poster, suggesting they confront their mother or find creative ways to intervene. One comment read, &#8220;Make a fake version of that site, so it sends payments to your bank account instead,&#8221; while others suggested blocking the church's website at the router level or trying to educate their loved ones about the realities of financial manipulation.
See Also: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
<h2 class="wp-block-heading">Family Strain and Difficult Conversations</h2>
A lot of people also pointed out that some people keep giving money to these churches even when they can barely pay their own bills. One user reflected on a family member's situation, saying, &#8220;I work with a lady in a nursing home that receives $85 a month from Medicaid. She's constantly bugging people about a dollar here or there for a Coke or snack because &#8216;$85 can't buy anything.&#8217; Few years back I learned she gives $1,000 to $1,200 to the church every year. You do the math.&#8221;
The thread became a broader discussion about the ethics of megachurches and the financial pressures they place on their followers, with some comparing the practice to a form of financial addiction. One person wrote, &#8220;They promise if she gives enough that God will also make her wealthy beyond her dreams,&#8221; showing how these churches can use emotional appeals to keep people giving.
Another commenter captured the frustration many felt, writing, &#8220;It breaks my heart to see these charlatans deluding gullible people like this. They&#8217;re cynically exploiting greed in the guise of generosity. It's infuriating.&#8221;
As the original poster hinted at confronting their mother, the thread served as a stark reminder of the deep divides such financial choices can create within families.
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

'My Mom Says We Don't Have Enough Money' Complains A Frustrated Family Member 'But I Catch Her Giving Thousands To A Megachurch Every Month'

CLDI

Calidi Biotherapeutics 13G Filing Shows Armistice Capital Reported A 9.99% Stake In The Co As Of March 31, 2025

Meta shares are trading lower following a report indicating the company is delaying the rollout of its AI model.

<a href="https://www.wsj.com/tech/ai/meta-is-delaying-the-rollout-of-its-flagship-ai-model-f4b105f7" title="https://www.wsj.com/tech/ai/meta-is-delaying-the-rollout-of-its-flagship-ai-model-f4b105f7">https://www.wsj.com/tech/ai/meta-is-delaying-the-rollout-of-its-flagship-ai-model-f4b105f7</a>

'Meta Is Delaying The Release Of Its "Behemoth" AI Model Due To Concerns About Its Capabilities; Meta Is Contemplating Management Changes To Its Ai Product Group Due To The Performance Of The Llama 4 Team' - WSJ

After a sharp rally over the past three weeks, the cryptocurrency market is entering a consolidation phase, with Bitcoin showing resilience even as Ethereum, XRP, and Dogecoin edge lower. Some analysts believe we may be seeing profit-taking after recent highs.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$102,910.08</td>
<td>-0.6%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,535.58</td>
<td>-2.9%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$170.15</td>
<td>-3.6%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.43</td>
<td>-4.7%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.2211</td>
<td>-5.3%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001478</td>
<td>-6.5%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows large transaction volume decreasing by 5.1% and daily active addresses falling by 1.9%. Transactions greater than $100,000 are down from 11,891 to 11,304 in a single day. Exchanges netflows are down by 91.5%.</li>
<li>Coinglass data reports 170,572 traders were liquidated in the past 24 hours for $401.84 million.</li>
</ul>
Notable Developments:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/05/45446885/mastercard-taps-into-100-million-crypto-users-with-moonpay-partnership">Mastercard Taps Into 100 Million Crypto Users With MoonPay Partnership</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45436694/ethereums-surge-could-kick-off-the-2025-altcoin-bull-market-experts-say">Ethereum&#8217;s Surge Could Kick Off The 2025 &#8216;Altcoin Bull Market&#8217;, Experts Say</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45444794/bitcoin-is-starting-to-outperform-gold-jpmorgan">Bitcoin Is Starting To Outperform Gold: JPMorgan</a></li>
<li><a href="https://www.benzinga.com/25/05/45441382/cardano-surges-amid-new-users-ada-futures-interest-nears-1-billion">Cardano Surges Amid New Users, ADA Futures Interest Nears $1 Billion</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45441997/coinbase-hit-by-data-breach-refuses-to-pay-20m-ransom">Coinbase Hit By Data Breach, Refuses To Pay $20M Ransom</a></li>
</ul>
Top Losers":
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Pudgy Penguins (CRYPTO: PENGU)</td>
<td>$0.01363</td>
<td>-14.9%</td>
</tr>
<tr>
<td>Theta Network (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/theta/usd">THETA</a>)</td>
<td>$0.9069</td>
<td>-8.7%</td>
</tr>
<tr>
<td>Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>)</td>
<td>$1.01</td>
<td>-8.7%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: More Crypto Online <a href="https://x.com/Morecryptoonl/status/1923061459375829344">predicts</a> Bitcoin could test $105,700, aligning with the 100% Fibonacci extension, marking a critical resistance zone.
Trader Roman <a href="https://x.com/Roman_Trading/status/1923056678280290366">noted</a> a healthy bounce in price, though he remains cautious, watching whether BTC can hold the consolidation zone into next week.
Daan Crypto Trades <a href="https://x.com/DaanCrypto/status/1923041905257894141">highlighted</a> that BTC is far from major liquidity zones and hasn't spent much time at these elevated levels. 
With limited new position buildup post-short squeeze, key levels to watch include resistance above $106,000 and support down at $93,000, the origin of the recent move.
ShardiB2 advised traders to stay focused, saying "Bitcoin looks good—don't get distracted by short-term noise."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Like I keep saying, looks good, don&#39;t get distracted by short term noise <a href="https://t.co/xgc6u6bSbA">https://t.co/xgc6u6bSbA</a> <a href="https://t.co/0xp8wuV4S2">pic.twitter.com/0xp8wuV4S2</a>
&mdash; Don&#39;t follow Shardi B if you hate Money (@ShardiB2) <a href="https://twitter.com/ShardiB2/status/1923060961348334004?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto investor Ted Pillows believes BTC may be in the final phase of Wyckoff accumulation, showing strength above $100,000. 
He also pointed to a recent $2 billion USDT mint, signaling new liquidity that could fuel a breakout toward $120,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BTC Wyckoff accumulation is in the final phase. Some consolidation is happening above $100K which is a good sign. USDT just minted $2B, and that means liquidity is entering again. I think the next leg up will soon start and send <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> above $120K. <a href="https://t.co/IowicUkiVo">pic.twitter.com/IowicUkiVo</a>
&mdash; Ted (@TedPillows) <a href="https://twitter.com/TedPillows/status/1923008417230196851?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45445674/bitcoin-eyes-108000-but-one-thing-stands-in-the-way">Bitcoin Eyes $108,000, But One Thing Stands In The Way </a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$THETA

$WIF

$XRP

Bitcoin Holding Up While Ethereum, XRP, Dogecoin Dip: 'Don't Get Distracted By Short Term Noise,' Trader Says

Shares of Luminar Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) plunged 16.3% to $3.985 on Thursday afternoon after the company <a href="https://www.benzinga.com/news/earnings/25/05/45423511/luminar-technologies-shares-slip-after-q1-results-new-operating-plan">reported</a> first-quarter results and announced a major leadership transition.
What To Know: While Luminar beat Wall Street expectations, posting a loss of $1.50 per share versus an expected $1.78, and revenue of $18.89 million versus a $15.98 million estimate, investors reacted sharply to news that CEO and founder Austin Russell has resigned following a <a href="https://www.benzinga.com/news/earnings/25/05/45423511/luminar-technologies-shares-slip-after-q1-results-new-operating-plan">board-led ethics inquiry</a>. The company confirmed that the investigation did not affect financial results.
Russell will remain on the board, with former Nuance CEO Paul Ricci set to <a href="https://www.benzinga.com/pressreleases/25/05/b45423503/luminar-announces-leadership-transition">take over</a> on May 21. Ricci brings a track record in scaling tech companies and building AI-driven platforms.
Read Also: <a href="https://www.benzinga.com/25/05/45445629/whats-going-on-with-ibotta-stock-thursday">What&#8217;s Going On With Ibotta Stock Thursday?</a>
Alongside earnings, Luminar unveiled a new unified product architecture and operating plan aimed at halving non-GAAP operational expenditures by the end of fiscal 2025. CEO Russell characterized the plan as a move to "ramp up production, ramp down costs, and capitalize on the future."
Despite positive financial beats and future-focused plans, the leadership shakeup and surrounding uncertainty appears to have rattled investors during Thursday&#8217;s session.
Read Also: <a href="https://www.benzinga.com/25/05/45445485/coreweave-stock-surges-to-highs-of-the-session-after-company-reveals-details-of-openai-deal">CoreWeave Stock Surges To Highs Of The Session After Company Reveals Details Of OpenAI Deal</a>
<h2 class="wp-block-heading">How To Buy LAZR Stock</h2>
By now you're likely curious about how to participate in the market for Luminar Technologies &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, LAZR has a 52-week high of $32.62 and a 52-week low of $3.30.

LAZR

Luminar (LAZR) Stock Drops Sharply Following Q1 Earnings, CEO Shakeup

DAT Freight & Analytics Acquires Outgo, Redefining Freight Payments; Terms Not Disclosed

The stock of Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) is trading higher on Thursday. But along with the rest of the healthcare sector, it is still in a steep downtrend. The news regarding <a href="https://www.benzinga.com/general/health-care/25/05/45443695/why-is-unitedhealth-stock-trading-lower-on-thursday">potential fraud at</a> UnitedHealth Group Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NASDAQ">UNH</a>) has put pressure on the entire sector.
But there is a good chance that Amgen finds a bottom soon. It may even reverse and head higher. This is why we have named it our Stock of the Day.
The shares are oversold.
The lower part of the chart is the Stochastics Momentum Indicator. If the blue line is below the lower horizontal red line, it indicates oversold conditions. As you can see, that is the case now.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-1024x560.png" alt="" class="wp-image-917099" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN.png 1488w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
This means that the shares have been aggressively sold and are trading below their typical or normal range. This could draw buyers into the market.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45435725/tariffs-slow-retail-spending-as-producer-prices-post-sharpest-drop-since-2020">Tariffs Slow Retail Spending As Producer Prices Post Sharpest Drop Since 2020</a>
Many trading strategies are based on the concept of reversion to the mean. This means buyers will be anticipating a reversal or move higher and their buying may become a self-fulfilling prophecy.
The shares are also getting close to a potential support level.
$255.50 was support in March 2023. It was also support in December 2024. Price levels that had previously been support can become so again because of trader and investor psychology.
Sometimes, people who sell shares while a stock is at a support level come to regret their decision to do so if the price rallies after. Many decide that if they eventually can, they will buy their shares back at the same price they sold them for.
As a result, if the stock eventually reverses and drops back to the support level, they place buy orders. If there are enough of them it will create support at the price again.
This is what happened with Amgen. If it continues to trend lower there is a good chance that it finds support at this important price again.
There is also a good chance that it rallies and reverses off of this level for a third time.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45436534/walmart-doesnt-alter-annual-outlook-yet-ceo-says-all-tariffs-create-cost-pressures-but-china-has-biggest-impact">Walmart Doesn&#8217;t Alter Annual Outlook Yet, CEO Says &#8216;All Tariffs Create Cost Pressures But China Has Biggest Impact&#8217;</a></li>
</ul>
Photo: Shutterstock

Technicals

AMGN

Stock Of The Day: Amgen Slips With Healthcare Sector, But Signals Point To A Reversal

<a href="https://www.commerce.gov/news/press-releases/2025/05/uae/us-framework-advanced-technology-cooperation" title="https://www.commerce.gov/news/press-releases/2025/05/uae/us-framework-advanced-technology-cooperation">https://www.commerce.gov/news/press-releases/2025/05/uae/us-framework-advanced-technology-cooperation</a>

Politics

Global

AMZN

White House Fact Sheet Says Amazon Web Services And UAE Cybersecurity Council Have Launched A Sovereign Cloud Launchpad; RTX Partnering With Emirates' Global Aluminum And UAE's Tawazun Council On Gallium Critical Minerals Project

Trump Secures $200B In New U.S-UAE Deals And Accelerates Previously Committed $1.4T Investment; Boeing And GE Aerospace Secured $14.5B Commitment From Etihad Airways To Invest In 28 American-Made Boeing 787 And 777x Aircraft Powered By GE Engines; Emirates Global Aluminum Will Invest $4B To Develop Primary Aluminum Smelter Project In Oklahoma; Exxon Mobil, Occidental Petroleum, And EOG Resources Are Partnering With The Abu Dhabi National Oil Company For Expanded Oil And Natural Gas Production Valued At $60B

Addentax Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>), a China-based diversified business group, stock skyrocketed on Thursday after it announced plans to <a href="https://www.benzinga.com/pressreleases/25/05/n45436963/addentax-group-corp-announces-800-million-plan-to-acquire-bitcoin-btc-and-official-trump-trump">acquire up to $800 million in crypto</a> via a share-based deal. The stock gave up its gains later.
The company announced plans to acquire up to 8,000 Bitcoins and other major cryptocurrencies, worth around $800 million, through a potential share-based transaction, signaling a major strategic pivot into the digital asset space.
The company is negotiating with several influential cryptocurrency holders to purchase up to 8,000 Bitcoins and assets such as the Official Trump coin. Based on current market prices, the estimated value of the proposed acquisition stands at approximately $800 million. While the discussions are advancing, no definitive agreement has been finalized.
ATXG views the potential transaction as a key component of its long-term strategy to expand its presence in the digital asset space. By issuing common stock in exchange for crypto assets, the company aims to strengthen its balance sheet while bringing experienced crypto investors into its shareholder network.
Also Read: <a href="https://www.benzinga.com/etfs/sector-etfs/25/05/45428416/cathie-wood-tesla-palantir-coinbase-shopify-are-tip-of-the-spear-as-innovation-leaves-indexes-sc">Cathie Wood Says Palantir, Tesla, Coinbase And This Amazon Rival Are &#8216;Tip Of The Spear&#8217; As Innovation Disrupts Old World In Equity Benchmarks</a>
The targeted holders, who are believed to collectively control roughly 8,000 Bitcoins, bring substantial expertise and connections within the cryptocurrency industry. ATXG intends to leverage these relationships to deepen its market reach and accelerate growth in the blockchain sector.
CEO Hong Zhida said the move is part of a broader strategy to position Addentax within the evolving digital economy. "This initiative supports the Company's broader blockchain strategy by facilitating potential acquisitions of digital assets such as Bitcoin and introducing strategic investors with experience in the crypto ecosystem," he said. He added that established digital currencies could serve as stable long-term holdings due to their liquidity and increasing institutional interest.
Related ETFs: Bitwise Crypto Industry Innovators ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITQ#NYSE">BITQ</a>), Valkyrie Bitcoin Strategy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTF#NASDAQ">BTF</a>)
Price Action: ATXG shares are trading higher by 75.32% at $1.26 at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45427302/anthony-scaramucci-forecasts-bitcoin-will-be-deemed-asset-class-akin-to-gold-when-it-reaches-500000">Anthony Scaramucci Says Once Bitcoin Hits $500,000 It Will Be Considered An Asset Class Just Like Gold</a></li>
</ul>
Photo Courtesy: alfernec via Shutterstock

ATXG

BITQ

MSTR

Addentax Takes $800 Million Bet On Bitcoin And Crypto

Press Releases

Commercial Real Estate in a Post-Pandemic World: Five Years Later

Cushman & Wakefield to Release First Quarter 2025 Earnings on April 29

Cushman & Wakefield Recognized by IAOP® as an "All Star" Outsourcing Firm and for "Sustained Excellence"

Cushman & Wakefield Reports Financial Results for the First Quarter 2025

Adam Pastor Joins Cushman & Wakefield as Vice Chair in the Firm's Industrial Advisory Group

Cushman & Wakefield Welcomes Rob Borden and Heather Brown as Vice Chairs in Boston

Industry-leading Office Agency Leasing Team of Eric Siegrist, Amanda Nebel and JP Hutcheson Joins Cushman & Wakefield in Houston

Surging Demand for Data Infrastructure Fuels Real Estate Transformation Across Global Data Center Markets According to Cushman & Wakefield

Cushman & Wakefield Hires Rich Okoney as Global Data Center Facilities Management Practice Lead

Cushman & Wakefield Recognized by USA TODAY as One of America's Climate Leaders 2025

Altisource Portfolio Solutions S.A. - Common Stock

Altisource Portfolio

KE Holdings Inc American Depositary Shares (each representing three Class A Ordinary Shares)

Comments

Cushman & Wakefield

Actualités

Dernières nouvelles pour Cushman & Wakefield (NYSE:CWK) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL